Gerresheimer at Pharmapack 2024: Innovative solutions and expert presentations
Broad portfolio for biologics, including cell and gene therapy products Digitally connected Drug Delivery Devices for s…
Broad portfolio for biologics, including cell and gene therapy products Digitally connected Drug Delivery Devices for s…
Breites Portfolio für Biologika, einschließlich Zell- und Gentherapieprodukte Digital vernetzte Drug Delivery Devices…
With innovative, solution-oriented, and sustainable developments, the Gerresheimer team presents itself at Pharmapack an…
On August 27, Gerresheimer Boleslawiec S.A. celebrates its 70th anniversary in Poland. Founded in 1952, the industrial p…
According to Future Market Insights (FMI), the demand for ocular drug delivery system is expected to rise considerably,…
On 21 September 2021, the founding members of the expert panel AG PolyMORE met at ETH Zurich for the first consortium me…
. Transparency Market Research (TMR) has published a new report on the corneal topographers market for the forecast peri…
According to the report, the global corneal topographers market was valued at ~US$ 920 Mn in 2018, and is projected to e…
VSY Biotechnology, leading ophthalmic and orthopedic medical device and biotechnology company, announces the appointment…
. - Collaboration with Biogen to develop gene therapy for an undisclosed target to treat inherited eye disease, plus op…